Company News

Company News

August 19, 2013
Piramal Imaging Provides Comments in Response to the Centers for Medicare and Medicaid Services (CMS) Proposed Coverage Decision for Beta-Amyloid Positron Emission Tomography (PET).
PDF Read more


July 25, 2013
The Centers for Medicare and Medicaid Services (CMS) Draft Decision Could Limit Patient Access to New Technology That May Help in Diagnosing Dementia.
PDF Read more


July 12, 2013
Piramal Imaging Highlights New Data for Florbetaben F18 at AAIC 2013.
PDF Read more


June 6, 2013
Piramal Imaging Highlights New Data for Florbetaben and Other Investigational Radiopharmaceuticals at SNMMI 2013.
PDF Read more


May 7, 2013
Piramal Imaging Welcomes Ana M. Catafau, MD, PhD, as VP, Clinical Research and Development, Neurosciences.
PDF Read more


March 21, 2013
Piramal Imaging announces the acceptance for review of [18F] florbetaben by the FDA and EMA for the visual detection of beta-amyloid in Alzheimer’s disease.
PDF Read more


August 30, 2012
Indian Pharma MNC Piramal investing in German molecular imaging technology.
PDF Read more


April 15, 2012
Piramal Healthcare Limited acquires molecular imaging development portfolio of Bayer Pharma.
PDF Read more